Berman Tabacco Announces Investigation of EyePoint Pharmaceuticals, Inc. (EYPT) for Potential Securities Law Violations

August 31, 2022 12:37 PM EDT | Source: Berman Tabacco

Boston, Massachusetts--(Newsfile Corp. - August 31, 2022) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by EyePoint Pharmaceuticals, Inc. ("EyePoint" or "the Company") (NASDAQ: EYPT), a company based in Watertown, Massachusetts.

About the Investigation

On August 30, 2022, after the market close, EyePoint filed a Form 8-K with the U.S. Securities and Exchange Commission disclosing that "[o]n August 22, 2022, [EyePoint] received an unsigned version of a subpoena from the U.S. Attorney's Office for the District of Massachusetts seeking production of documents related to sales, marketing and promotional practices, including as pertain to DEXYCU®."

On this news, shares were down in early trading on August 31, 2022.

If you sustained losses from your transactions in EyePoint securities and would like to discuss your legal rights and/or options, please provide your information here: Shareholder Contact | Berman Tabacco.

Berman Tabacco typically represents individuals and entities in class actions on a contingency fee basis, meaning we advance all attorneys' fees and expenses in the litigation. If the case is successful, the firm will ask the court to award the firm attorneys' fees and the reimbursement of expenses from any settlement fund. If we are not successful, you will not be responsible for the reimbursement of attorneys' fees or expenses.

About Berman Tabacco

Berman Tabacco is a national law firm representing institutions and individuals in lawsuits, seeking to recoup losses caused by corporate and board misconduct and violations of the securities and antitrust laws. The firm has offices in Boston, Massachusetts and San Francisco, California.

This notice may constitute attorney advertising.

Contact:

Berman Tabacco
Jay Eng, Esq.
One Liberty Square
Boston, Massachusetts
(800) 516-9926
Email: law@bermantabacco.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/135544

info